Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J de Bree

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
The Lancet. Microbe|October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort studyBernadette Schurink, Eva Roos, Teodora Radonic, et al.
Journal of Clinical Immunology|October 9, 2025
Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Journal of Clinical Immunology|August 25, 2025
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Science (New York, N.Y.)|June 17, 2020
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerabilityPhilip J M Brouwer, Tom G Caniels, Karlijn van der Straten, et al.
The Lancet. Microbe|October 5, 2020
Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort studyBernadette Schurink, Eva Roos, Teodora Radonic, et al.
Journal of Clinical Immunology|October 9, 2025
Correction to: Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Journal of Clinical Immunology|August 25, 2025
Self-reported Clinical Outcomes and Quality of Life in Agammaglobulinemia: the Importance of an Early DiagnosisMaartje Blom, Annelotte J Duintjer, Mahnaz Jamee, et al.
Science Translational Medicine|May 12, 2021
High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophagesWillianne Hoepel, Hung-Jen Chen, Chiara E Geyer, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Nature Communications|November 21, 2025
HIV-1 envelope trimer vaccine induces sex-associated differences in antibody responses: a phase 1 clinical trialEmma I M M Reiss, Karlijn van der Straten, Laura T M Graus, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Cell|February 12, 2021
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infectionPhilip J M Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Pageof 19